AKR1D1 and myeloid sarcoma: Molar ratios, which may reflect AKR1D1 functioning, did not show a significant trend associated with MS (2/11/0, p = 0.175), nor did the associations of these molar ratios with EDSS, T25FWT, HPT9_R, and HPT9_L in patients (0/13/0, p = 1), (0/13/0, p = 1), (2/11/0, p = 0.175), and (2/11/0, p = 0.175), respectively.